Company Filing History:
3 out of 3 
2 out of 2 
1 out of 1 
Years Active: 2016-2024
Title: The Innovations of Wen Kang Xu
Introduction
Wen Kang Xu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a total of 8 patents to his name, Xu's work is paving the way for new therapeutic options in cancer treatment.
Latest Patents
Xu's latest patents include innovative compounds that serve as kinase inhibitors. One notable patent describes heterocyclic compounds that are potentially useful in treating various diseases, including cancers. The disclosure provides a compound of Formula (I) and/or its stereoisomers, tautomers, stable isotopes, or pharmaceutically acceptable salts. Additionally, another patent focuses on compounds that inhibit tryptophan 2, 3-dioxygenase 2 (TDO2) and indoleamine 2, 3-dioxygenase 1 (IDO1), which are also aimed at cancer treatment.
Career Highlights
Throughout his career, Wen Kang Xu has worked with notable companies such as Js Innopharm and Changzhou Jiekai Pharmatech Co., Ltd. His expertise in pharmaceutical research has led to significant advancements in drug development.
Collaborations
Xu has collaborated with several professionals in his field, including Jintao Zhang and Shanzhong Jian, who have contributed to his research endeavors.
Conclusion
Wen Kang Xu's innovative work in the pharmaceutical industry highlights his commitment to advancing cancer treatment through the development of novel compounds. His contributions are essential in the ongoing fight against cancer and showcase the importance of innovation in medicine.